The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Michael E. Menefee
No Relationships to Disclose
 
Lynn C. Hartmann
No Relationships to Disclose
 
Harry J. Long
No Relationships to Disclose
 
Donald W. Northfelt
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Fleix Boakye-Agyeman
No Relationships to Disclose
 
Karen S Flatten
No Relationships to Disclose
 
Guy G Poirier
No Relationships to Disclose
 
Janet Lensing
No Relationships to Disclose
 
Charles Erlichman
No Relationships to Disclose
 
Scott H. Kaufmann
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Millipore; Millipore (Inst)
 
Paul Haluska
Stock and Other Ownership Interests - Boehringer Ingelheim
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim (I)
Research Funding - Clovis Oncology (Inst); Genentech (Inst); MedImmune (Inst); Merck (Inst); Nektar (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Mayo Avatar Program; Mayo Avatar Program (Inst)
Travel, Accommodations, Expenses - Boston Biomedical